Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1995 Jun 1;181(6):2271–2275. doi: 10.1084/jem.181.6.2271

Neutral endopeptidase modulation of septic shock

PMCID: PMC2192063  PMID: 7760013

Abstract

Neutral endopeptidase (NEP; EC. 3.4.24.11) is a type 2 cell surface metalloprotease known by a variety of eponyms, including enkephalinase, common acute lymphoblastic leukemia antigen, and CD10. Identified substrates are largely neural or humoral oligopeptide agonists, and the enzyme functions to terminate signaling by degrading the ligand, analogously to acetylcholine/acetylcholinesterase. Targeted disruption of the NEP locus in mice results in enhanced lethality to endotoxin shock with a pronounced gene dosage effect. The site(s) of action appears downstream from release of tumor necrosis factor and interleukin-1 since NEP-deficient animals demonstrate increased sensitivity to these mediators as well. This unexpected finding indicates an important protective role for NEP in septic shock.

Full Text

The Full Text of this article is available as a PDF (1.9 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brown G., Hogg N., Greaves M. Candidate leukaemia-specific antigen in man. Nature. 1975 Dec 4;258(5534):454–456. doi: 10.1038/258454a0. [DOI] [PubMed] [Google Scholar]
  2. Christopher T. A., Ma X. L., Gauthier T. W., Lefer A. M. Beneficial actions of CP-0127, a novel bradykinin receptor antagonist, in murine traumatic shock. Am J Physiol. 1994 Mar;266(3 Pt 2):H867–H873. doi: 10.1152/ajpheart.1994.266.3.H867. [DOI] [PubMed] [Google Scholar]
  3. Erdös E. G., Skidgel R. A. Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones. FASEB J. 1989 Feb;3(2):145–151. [PubMed] [Google Scholar]
  4. Everaerdt B., Brouckaert P., Shaw A., Fiers W. Four different interleukin-1 species sensitize to the lethal action of tumour necrosis factor. Biochem Biophys Res Commun. 1989 Aug 30;163(1):378–385. doi: 10.1016/0006-291x(89)92146-3. [DOI] [PubMed] [Google Scholar]
  5. Fleming I., Dambacher T., Busse R. Endothelium-derived kinins account for the immediate response of endothelial cells to bacterial lipopolysaccharide. J Cardiovasc Pharmacol. 1992;20 (Suppl 12):S135–S138. doi: 10.1097/00005344-199204002-00038. [DOI] [PubMed] [Google Scholar]
  6. Gearing A. J., Beckett P., Christodoulou M., Churchill M., Clements J., Davidson A. H., Drummond A. H., Galloway W. A., Gilbert R., Gordon J. L. Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature. 1994 Aug 18;370(6490):555–557. doi: 10.1038/370555a0. [DOI] [PubMed] [Google Scholar]
  7. Gros C., Souque A., Schwartz J. C. Inactivation of atrial natriuretic factor in mice in vivo: crucial role of enkephalinase (EC 3.4.24.11). Eur J Pharmacol. 1990 Apr 10;179(1-2):45–56. doi: 10.1016/0014-2999(90)90400-z. [DOI] [PubMed] [Google Scholar]
  8. Hartmann F., Poirier M. F., Bourdel M. C., Loo H., Lecomte J. M., Schwartz J. C. Comparison of acetorphan with clonidine for opiate withdrawal symptoms. Am J Psychiatry. 1991 May;148(5):627–629. doi: 10.1176/ajp.148.5.627. [DOI] [PubMed] [Google Scholar]
  9. Hewett J. A., Roth R. A. Hepatic and extrahepatic pathobiology of bacterial lipopolysaccharides. Pharmacol Rev. 1993 Dec;45(4):382–411. [PubMed] [Google Scholar]
  10. Kee B. L., Paige C. J., Letarte M. Characterization of murine CD10, an endopeptidase expressed on bone marrow adherent cells. Int Immunol. 1992 Sep;4(9):1041–1047. doi: 10.1093/intimm/4.9.1041. [DOI] [PubMed] [Google Scholar]
  11. King K. A., Hua J., Torday J. S., Drazen J. M., Graham S. A., Shipp M. A., Sunday M. E. CD10/neutral endopeptidase 24.11 regulates fetal lung growth and maturation in utero by potentiating endogenous bombesin-like peptides. J Clin Invest. 1993 May;91(5):1969–1973. doi: 10.1172/JCI116417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kurihara Y., Kurihara H., Suzuki H., Kodama T., Maemura K., Nagai R., Oda H., Kuwaki T., Cao W. H., Kamada N. Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature. 1994 Apr 21;368(6473):703–710. doi: 10.1038/368703a0. [DOI] [PubMed] [Google Scholar]
  13. Lehmann V., Freudenberg M. A., Galanos C. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J Exp Med. 1987 Mar 1;165(3):657–663. doi: 10.1084/jem.165.3.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lieschke G. J., Grail D., Hodgson G., Metcalf D., Stanley E., Cheers C., Fowler K. J., Basu S., Zhan Y. F., Dunn A. R. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood. 1994 Sep 15;84(6):1737–1746. [PubMed] [Google Scholar]
  15. Malfroy B., Swerts J. P., Guyon A., Roques B. P., Schwartz J. C. High-affinity enkephalin-degrading peptidase in brain is increased after morphine. Nature. 1978 Nov 30;276(5687):523–526. doi: 10.1038/276523a0. [DOI] [PubMed] [Google Scholar]
  16. Marsden P. A., Brenner B. M. Transcriptional regulation of the endothelin-1 gene by TNF-alpha. Am J Physiol. 1992 Apr;262(4 Pt 1):C854–C861. doi: 10.1152/ajpcell.1992.262.4.C854. [DOI] [PubMed] [Google Scholar]
  17. McGeehan G. M., Becherer J. D., Bast R. C., Jr, Boyer C. M., Champion B., Connolly K. M., Conway J. G., Furdon P., Karp S., Kidao S. Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor. Nature. 1994 Aug 18;370(6490):558–561. doi: 10.1038/370558a0. [DOI] [PubMed] [Google Scholar]
  18. Mohler K. M., Sleath P. R., Fitzner J. N., Cerretti D. P., Alderson M., Kerwar S. S., Torrance D. S., Otten-Evans C., Greenstreet T., Weerawarna K. Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing. Nature. 1994 Jul 21;370(6486):218–220. doi: 10.1038/370218a0. [DOI] [PubMed] [Google Scholar]
  19. Painter R. G., Dukes R., Sullivan J., Carter R., Erdös E. G., Johnson A. R. Function of neutral endopeptidase on the cell membrane of human neutrophils. J Biol Chem. 1988 Jul 5;263(19):9456–9461. [PubMed] [Google Scholar]
  20. Petersson G., Bacci E., McDonald D. M., Nadel J. A. Neurogenic plasma extravasation in the rat nasal mucosa is potentiated by peptidase inhibitors. J Pharmacol Exp Ther. 1993 Jan;264(1):509–514. [PubMed] [Google Scholar]
  21. Ritz J., Pesando J. M., Notis-McConarty J., Lazarus H., Schlossman S. F. A monoclonal antibody to human acute lymphoblastic leukaemia antigen. Nature. 1980 Feb 7;283(5747):583–585. doi: 10.1038/283583a0. [DOI] [PubMed] [Google Scholar]
  22. Roques B. P., Fournié-Zaluski M. C., Soroca E., Lecomte J. M., Malfroy B., Llorens C., Schwartz J. C. The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice. Nature. 1980 Nov 20;288(5788):286–288. doi: 10.1038/288286a0. [DOI] [PubMed] [Google Scholar]
  23. Salles G., Rodewald H. R., Chin B. S., Reinherz E. L., Shipp M. A. Inhibition of CD10/neutral endopeptidase 24.11 promotes B-cell reconstitution and maturation in vivo. Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7618–7622. doi: 10.1073/pnas.90.16.7618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Stimler-Gerard N. P. Neutral endopeptidase-like enzyme controls the contractile activity of substance P in guinea pig lung. J Clin Invest. 1987 Jun;79(6):1819–1825. doi: 10.1172/JCI113023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Tamaoki J., Chiyotani A., Kobayashi K., Sakai N., Kanemura T., Takizawa T. Effect of indomethacin on bronchorrhea in patients with chronic bronchitis, diffuse panbronchiolitis, or bronchiectasis. Am Rev Respir Dis. 1992 Mar;145(3):548–552. doi: 10.1164/ajrccm/145.3.548. [DOI] [PubMed] [Google Scholar]
  26. Tybulewicz V. L., Crawford C. E., Jackson P. K., Bronson R. T., Mulligan R. C. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell. 1991 Jun 28;65(7):1153–1163. doi: 10.1016/0092-8674(91)90011-m. [DOI] [PubMed] [Google Scholar]
  27. Vijayaraghavan J., Scicli A. G., Carretero O. A., Slaughter C., Moomaw C., Hersh L. B. The hydrolysis of endothelins by neutral endopeptidase 24.11 (enkephalinase). J Biol Chem. 1990 Aug 25;265(24):14150–14155. [PubMed] [Google Scholar]
  28. Waage A., Espevik T. Interleukin 1 potentiates the lethal effect of tumor necrosis factor alpha/cachectin in mice. J Exp Med. 1988 Jun 1;167(6):1987–1992. doi: 10.1084/jem.167.6.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Xu D., Emoto N., Giaid A., Slaughter C., Kaw S., deWit D., Yanagisawa M. ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell. 1994 Aug 12;78(3):473–485. doi: 10.1016/0092-8674(94)90425-1. [DOI] [PubMed] [Google Scholar]
  30. Yong T., Gao X. P., Koizumi S., Conlon J. M., Rennard S. I., Mayhan W. G., Rubinstein I. Role of peptidases in bradykinin-induced increase in vascular permeability in vivo. Circ Res. 1992 May;70(5):952–959. doi: 10.1161/01.res.70.5.952. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES